Rates of Systemic Treatment for Metastatic Non–Small Cell Lung Cancer Among Older Adults

Дата публикации: 01-07-2026 00:00:00

This cohort study characterizes the prevalence of treatment for metastatic non–small cell lung cancer and predictors of its receipt over a time span ranging from when empiric cytotoxic regimens dominated to the recent availability of targeted therapies and immunotherapy.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer	0	10.24	01-07-2026
2	Temporal Trends in Lung Cancer Cases Diagnosed at Early Stage	0	5.63	01-07-2026
3	Treatment Delays in Early Age–Onset Colorectal Cancer	0	8.3	01-07-2026
4	Long-Term Adverse Effects and Complications After Prostate Cancer Treatment	0	9.73	01-12-2024
5	Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer	0	7.57	01-07-2026
6	Race, Secondary Treatment, and Survival in Localized Prostate Cancer	0	5.24	21-07-2026
7	PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression	0	15.58	01-07-2026
8	Individualized Stereotactic Ablative Radiotherapy for Lung Tumors	0	6.6	01-11-2023
9	Prognostic Features of Anti-Cancer Drugs Response in Resected/Unresected Primary Non-Small Cell Lung Cancer: A Retrospective Cohort Study	0	7	15-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 5.92. Источник: jamanetwork.com.